Overview

Topical Tranexamic Acid and FlosealĀ® in Total Knee Arthroplasty

Status:
Unknown status
Trial end date:
2017-08-01
Target enrollment:
Participant gender:
Summary
Our purpose of this study is to conduct a prospective randomized controlled trial to investigate the blood-conservation effect of this two topical hemostatic agents in primary TKA procedures in patients with a risk of thromboembolic events. We will also observe if there is increased risk of thromboembolism by use of topical hemostatic agents.
Phase:
Phase 4
Details
Lead Sponsor:
Chang Gung Memorial Hospital
Treatments:
Dalteparin
Enoxaparin
Heparin
Heparin, Low-Molecular-Weight
Thrombin
Tinzaparin
Tranexamic Acid
Tranylcypromine